Marshall Wace
ABMD

Marshall Wace’s Abiomed Inc ABMD Stock Holding History

Marshall Wace’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,803
Closed -$934K – 3705
2022
Q3 		$934K Sell
3,803
-1,632
-30% -$441K ﹤0.01% 2443
2022
Q2 		$1.35M Buy
+5,435
New +$1.47M ﹤0.01% 2264
2022
Q1 		– Sell
-143,416
Closed -$51.5M – 4309
2021
Q4 		$51.5M Buy
143,416
+113,062
+372% +$38.2M 0.1% 207
2021
Q3 		$9.88M Buy
+30,354
New +$10.3M 0.04% 562
2021
Q2 		– Sell
-17,783
Closed -$5.67M – 3337
2021
Q1 		$5.67M Buy
17,783
+14,394
+425% +$4.61M 0.03% 764
2020
Q4 		$1.1M Buy
3,389
+463
+16% +$128K 0.01% 1172
2020
Q3 		$811K Buy
+2,926
New +$843K 0.01% 1099
2020
Q1 		– Sell
-88
Closed -$15K – 2195
2019
Q4 		$15K Sell
88
-14
-14% -$2.6K ﹤0.01% 1598
2019
Q3 		$18K Sell
102
-38,062
-100% -$8.23M ﹤0.01% 1603
2019
Q2 		$9.94M Buy
38,164
+33,615
+739% +$8.92M 0.08% 280
2019
Q1 		$1.3M Buy
4,549
+1,219
+37% +$405K 0.01% 860
2018
Q4 		$1.08M Sell
3,330
-40,010
-92% -$13.9M 0.01% 898
2018
Q3 		$19.5M Buy
43,340
+21,771
+101% +$8.58M 0.17% 170
2018
Q2 		$8.82M Buy
21,569
+15,449
+252% +$5.6M 0.13% 197
2018
Q1 		$1.78M Sell
6,120
-2,710
-31% -$687K 0.07% 205
2017
Q4 		$1.66M Buy
8,830
+126
+1% +$23.5K 0.07% 207
2017
Q3 		$1.47M Buy
+8,704
New +$1.32M 0.07% 189
2017
Q1 		– Sell
-55,113
Closed -$6.21M – 830
2016
Q4 		$6.21M Buy
55,113
+19,858
+56% +$2.3M 0.04% 423
2016
Q3 		$4.53M Sell
35,255
-21,620
-38% -$2.59M 0.03% 431
2016
Q2 		$6.22M Buy
56,875
+43,556
+327% +$4.33M 0.05% 347
2016
Q1 		$1.26M Buy
13,319
+1,285
+11% +$108K 0.01% 661
2015
Q4 		$1.09M Sell
12,034
-69,416
-85% -$5.89M 0.01% 691
2015
Q3 		$7.55M Buy
81,450
+47,737
+142% +$4.21M 0.09% 220
2015
Q2 		$2.22M Buy
+33,713
New +$2.24M 0.03% 459

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Marshall Wace's ABMD Position: Q4 2022 in Review

Marshall Wace sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,803 shares — an estimated $934K sold.

Marshall Wace first reported a position in ABMD in Q2 2015 and held it in 24 quarters. The position peaked at $51.5M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Marshall Wace reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Marshall Wace sold 3,803 Abiomed Inc shares in Q4 2022, an estimated $934K.
  • Marshall Wace first reported a position in Abiomed Inc in Q2 2015 and held it in 24 quarters.
  • Marshall Wace's Abiomed Inc position peaked at $51.5M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.